- Home
- AHR vs RNA Comparison
AHR vs RNA Comparison
Compare AHR & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHR
- RNA
- Stock Information
- Founded
- AHR 2013
- RNA 2012
- Country
- AHR United States
- RNA United States
- Employees
- AHR N/A
- RNA N/A
- Industry
- AHR
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- AHR
- RNA Health Care
- Exchange
- AHR NYSE
- RNA Nasdaq
- Market Cap
- AHR 4.2B
- RNA 4.4B
- IPO Year
- AHR 2024
- RNA 2020
- Fundamental
- Price
- AHR $27.88
- RNA $28.92
- Analyst Decision
- AHR Buy
- RNA Strong Buy
- Analyst Count
- AHR 8
- RNA 10
- Target Price
- AHR $26.13
- RNA $65.80
- AVG Volume (30 Days)
- AHR 2.0M
- RNA 1.4M
- Earning Date
- AHR 02-27-2025
- RNA 02-26-2025
- Dividend Yield
- AHR 3.58%
- RNA N/A
- EPS Growth
- AHR N/A
- RNA N/A
- EPS
- AHR N/A
- RNA N/A
- Revenue
- AHR $2,005,322,000.00
- RNA $10,117,000.00
- Revenue This Year
- AHR N/A
- RNA N/A
- Revenue Next Year
- AHR $9.49
- RNA N/A
- P/E Ratio
- AHR N/A
- RNA N/A
- Revenue Growth
- AHR 9.88
- RNA N/A
- 52 Week Low
- AHR $12.63
- RNA $9.93
- 52 Week High
- AHR $29.99
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- AHR 49.66
- RNA 37.85
- Support Level
- AHR $26.40
- RNA $26.74
- Resistance Level
- AHR $28.37
- RNA $31.06
- Average True Range (ATR)
- AHR 0.69
- RNA 1.77
- MACD
- AHR -0.01
- RNA 0.24
- Stochastic Oscillator
- AHR 60.29
- RNA 37.85
About AHR AMERICAN HEALTHCARE REIT INC
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing primarily on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. They have four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of revenue through Integrated Senior Health Campuses segment.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.